H. Lundbeck AS - Company Profile

Powered by

All the sales intelligence you need on H. Lundbeck AS in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how H. Lundbeck AS fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with H. Lundbeck AS.

Back to companies

H. Lundbeck AS: Patents

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

View up-to-date information on H. Lundbeck AS patents, including inventor and filing insights.

Patent Trends

Publication Identifier Document Type Title Classification-CPC Publication Date
EP3529250B1 Grant Imidazopyrazinone, pyrazolopyrimidinone und pyrazolopyridinone als pde1-inhibitoren A61P25/00; A61P25/14; A61P25/16; A61P25/18; A61P25/22; A61P25/24; A61P25/28; A61P43/00; C07D471/04; C07D487/04 December 06, 2023
ZA202103975B Grant Methods of treating disease with magl inhibitors A61K31/407; A61K31/4155; A61K31/437; A61K31/438; A61K31/454; A61K31/496; A61K31/506; A61K31/5377; A61K31/5386; A61K45/06; A61P1/00; A61P13/12; A61P17/00; A61P17/02; A61P19/00; A61P21/00; A61P25/00; A61P29/00; A61P3/00; A61P9/00 November 29, 2023
US11827665B2 Grant Process for the manufacture of (2S,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(((4AR,10AR)-7-hydroxy-1-propyl-1,2,3,4,4a,5,10,10a-octahydrobenzo[g]quinolin-6-yl)oxy)tetrahydro-2h-pyran-2-carboxylic acid C07H15/26 November 28, 2023
AU2017250815B2 Grant Humanized anti-pacap antibodies and uses thereof C12N15/09; C12N15/63; C12N5/06; A61K2039/505; A61K38/00; A61K38/17; A61K38/22; A61K39/3955; A61K48/00; A61P1/00; A61P1/02; A61P1/04; A61P1/16; A61P1/18; A61P11/00; A61P11/02; A61P11/06; A61P13/10; A61P13/12; A61P15/00; A61P17/00; A61P17/02; A61P17/04; A61P17/06; A61P17/10; A61P19/00; A61P19/02; A61P19/06; A61P19/10; A61P21/00; A61P25/00; A61P25/02; A61P25/04; A61P25/06; A61P25/08; A61P25/18; A61P25/22; A61P25/24; A61P25/30; A61P27/02; A61P27/06; A61P27/12; A61P29/00; A61P3/10; A61P31/04; A61P31/16; A61P31/22; A61P35/00; A61P35/02; A61P37/08; A61P5/24; A61P7/00; A61P7/06; A61P9/00; A61P9/04; A61P9/08; A61P9/10; A61P9/12; C07K14/47; C07K14/575; C07K14/70503; C07K14/72; C07K16/18; C07K16/26; C07K16/28; C07K16/2869; C07K16/4241; C07K2317/24; C07K2317/34; C07K2317/56; C07K2317/565; C07K2317/76; C07K2317/92; G01N2333/575; G01N33/6854; Y02A50/30 November 23, 2023
JP2023549051A Application Ｍａｇｌ阻害剤 A61K31/444; A61P25/00; A61P25/04; A61P25/08; C07D221/20; C07D401/12; C07D401/14; C07D405/12; C07D413/12; C07D417/12; C07D471/04; C07D487/04; C07F9/65583 November 22, 2023
Gain a 360-degree view of and make more informed decisions for your business Gain a 360-degree view of and make more informed decisions for your business Learn more

Top Inventors by Filings (Count by publication)

Name Count
Identify the top inventors associated with your target company when you unlock full profile Identify the top inventors associated with your target company when you unlock full profile Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer